Imedex® is an industry leader in providing certified, independent continuing medical education to health care professionals.

October 26-28, 2017

New York, New York
Sheraton New York


This conference is endorsed by the following organizations:

MDS Foundation

The Aplastic Anemia & MDS International Foundation (AA&MDSIF) is the world's leading nonprofit health organization dedicated to supporting patients and families living with aplastic anemia, myelodysplastic syndromes (MDS), paroxysmal nocturnal hemoglobinuria (PNH), and related bone marrow failure diseases. AA&MDSIF offers free patient education materials, conferences and an Online Learning Center with numerous programs on bone marrow failure diseases.  AA&MDSIF also has resources for health professionals, including educational programs and materials, a mobile app for MDS Risk Classification and Scoring, the Treating MDS Toolkit, a biennial Bone Marrow Failure Disease Scientific Symposium and research grants.


The Association of Physician Assistants in Oncology (APAO) is a non-profit 501(c) specialty organization affiliated with the American Academy of Physician Assistants (AAPA) that consists of physician assistants working in the field of oncology. It is the only national organization representing PAs specializing in oncology. Our members work in all oncology disciplines and practice in both clinical and research setting.


The Community Oncology Alliance (COA) is a non-profit organization dedicated to advocating for community oncology practices and, most importantly, the patients they serve. COA is the only organization dedicated to community oncology where close to 70% of Americans with cancer are treated.

The mission of the COA is to ensure that cancer patients receive quality, affordable, and accessible cancer care in their own communities. More than 1.5 million people in the United States are diagnosed with cancer each year and deaths from the disease have been steadily declining due to earlier detection, diagnosis, and treatment.

Elsevier | Practice Update is a free online resource for medical information and expert insight.

PracticeUpdate cuts through the mounds of medical literature, helping you focus on key updates in the least amount of time. Our experts review and hand-select the most important information from a variety of sources, adding critical insights and context. We won’t overload your inbox – read it on our site, or choose to receive as many or as few newsletters as you would like. A unique educational resource, at your fingertips, and completely free –

The International Society for Cutaneous Lymphomas (ISCL) is a 501(c)(3) non-profit medical society comprised of dermatologists, hematologists, radio-oncologists, pathologists and basic scientists, with the common purpose to increase the knowledge of lymphoproliferative and related disorders of the skin. The ISCL organizes annual scientific meetings as well as the World Congress for Cutaneous Lymphomas (WCCL) every three years, with the next one occurring October 26-28, 2016, in NYC. For more information on the ISCL, please visit, and for more information about the 3WCCL, please visit

Accomplishments include comparison of different methods to quantify skin tumor burden in cutaneous T cell lymphoma (CTCL), a consensus report on terminology and hematologic criteria for use in patients with erythrodermic CTCL, a scoring system for diagnosis of clinically typical mycosis fungoides, a consensus report on staging and classification of CTCL, as well as the formation of the Cutaneous Lymphoma International Consortium (CLIC), which stems from a shared vision that international collaboration will be imperative to have a greater impact on improving treatment and prognosis of patients with cutaneous lymphomas:

The International Waldenstrom’s Macroglobulinemia Foundation (IWMF) is a 501(c) (3) Non-Profit Organization. Our mission is to offer support and encouragement to the Waldenstrom’s macroglobulinemia community and others with an interest in the disease. IWMF provides information and educational programs that address patients’ concerns. We also promote and fund research leading to better treatments and ultimately, a cure.


The mission of The Leukemia & Lymphoma Society (LLS) is: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families.

LLS is the world's largest voluntary health agency dedicated to blood cancer. LLS funds lifesaving blood cancer research around the world and provides free information and support services.

LLS provides educational, emotional, and financial support to patients and families touched by blood cancers. We provide education and resources for healthcare professionals, and advocate for public policies that affect our cancer community. For additional information, please visit

Lymphoma Coalition

Founded in 2002, Lymphoma Coalition (LC) is a worldwide network of 66 lymphoma patient organisations from 44 countries that acts as a central hub for reliable and current information. Incorporated in 2010 and governed by a global Medical Advisory Board and Board of Directors, its mission is to:

  • Be the global source for lymphoma facts and statistics
  • Improve awareness and understanding of lymphomas
  • Build capacity for new and existing lymphoma groups


The Lymphoma Research Foundation (LRF) is the nation's largest non-profit organization devoted exclusively to funding innovative lymphoma research and providing people with lymphoma and healthcare professionals with up-to-date information about this type of cancer. LRF's mission is to eradicate lymphoma and serve those touched by this disease. LRF’s goal is to change the future for everyone whose life has been affected by a lymphoma diagnosis. LRF is dedicated to funding biomedical research focused on the origins, treatment and identification of a cure for lymphoma; to raising public awareness of the disease; and providing support and services to people with lymphoma, their families and caregivers.


The Multiple Myeloma Research Foundation (MMRF) was established in 1998 as a 501(c)(3) non-profit organization by twin sisters Karen Andrews and Kathy Giusti, soon after Kathy’s diagnosis with multiple myeloma. The mission of the MMRF is to relentlessly pursue innovative means that accelerate the development of next-generation multiple myeloma treatments to extend the lives of patients and lead to a cure. As the world’s number-one private funder of multiple myeloma research, the MMRF has raised $250 million since its inception and directs nearly 90% of total budget to research and related programming. As a result, the MMRF has been awarded Charity Navigator’s coveted four-star rating for 11 consecutive years, the highest designation for outstanding fiscal responsibility and exceptional efficiency. For more information about the MMRF, please visit:

NewYork-Presbyterian Hospital

NewYork-Presbyterian Hospital is one of the foremost academic medical centers in the world, with leading specialists in every field of medicine and a staff dedicated to the care of its patients.

NewYork-Presbyterian enjoys a unique affiliation with two of the nation’s leading Ivy League medical schools: Columbia University College of Physicians and Surgeons and Weill Cornell Medical College. With its academic partners, the Hospital shares a commitment to pursuing clinical excellence, engaging in groundbreaking biomedical research, offering outstanding medical education, and providing prevention and wellness services to the community.